JP2013537205A5 - - Google Patents

Download PDF

Info

Publication number
JP2013537205A5
JP2013537205A5 JP2013528537A JP2013528537A JP2013537205A5 JP 2013537205 A5 JP2013537205 A5 JP 2013537205A5 JP 2013528537 A JP2013528537 A JP 2013528537A JP 2013528537 A JP2013528537 A JP 2013528537A JP 2013537205 A5 JP2013537205 A5 JP 2013537205A5
Authority
JP
Japan
Prior art keywords
atoms
independently
alk
nyy
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013528537A
Other languages
English (en)
Japanese (ja)
Other versions
JP5731653B2 (ja
JP2013537205A (ja
Filing date
Publication date
Priority claimed from DE102010045890A external-priority patent/DE102010045890A1/de
Application filed filed Critical
Publication of JP2013537205A publication Critical patent/JP2013537205A/ja
Publication of JP2013537205A5 publication Critical patent/JP2013537205A5/ja
Application granted granted Critical
Publication of JP5731653B2 publication Critical patent/JP5731653B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013528537A 2010-09-17 2011-08-18 2,2’−フロイン誘導体および皮膚を明るくするためのその使用 Expired - Fee Related JP5731653B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102010045890.2 2010-09-17
DE102010045890A DE102010045890A1 (de) 2010-09-17 2010-09-17 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung
PCT/EP2011/004160 WO2012034629A1 (de) 2010-09-17 2011-08-18 2,2'-furoin-derivate und deren verwendung zur hautaufhellung

Publications (3)

Publication Number Publication Date
JP2013537205A JP2013537205A (ja) 2013-09-30
JP2013537205A5 true JP2013537205A5 (enExample) 2014-10-02
JP5731653B2 JP5731653B2 (ja) 2015-06-10

Family

ID=44584120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013528537A Expired - Fee Related JP5731653B2 (ja) 2010-09-17 2011-08-18 2,2’−フロイン誘導体および皮膚を明るくするためのその使用

Country Status (6)

Country Link
US (1) US8906351B2 (enExample)
EP (1) EP2616040B1 (enExample)
JP (1) JP5731653B2 (enExample)
CN (1) CN103179948A (enExample)
DE (1) DE102010045890A1 (enExample)
WO (1) WO2012034629A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8654815B1 (en) 2004-04-02 2014-02-18 Rearden, Llc System and method for distributed antenna wireless communications
US9469626B2 (en) 2012-07-03 2016-10-18 Colorado State University Research Foundation Biorefining compounds and organocatalytic upgrading methods
DE102013204070A1 (de) * 2013-03-11 2014-09-11 Beiersdorf Ag Verwendung kosmetisch oder dermatologisch unbedenklicher substituierter Michael-Akzeptoren zur Verhinderung, Verminderung oder Prophylaxe der Tyrosinaseaktivität der menschlichen Haut und/oder deren Aufhellung
CN107759542A (zh) * 2017-11-13 2018-03-06 天津工业大学 噻唑类离子液体催化糠醛耦合为糠偶姻
TWI839353B (zh) * 2018-06-28 2024-04-21 德商漢高股份有限及兩合公司 展現低固化溫度之含有潛還原劑的陽離子性可固化組合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE242625T1 (de) * 1990-04-26 2003-06-15 Procter & Gamble Chelat-zubereitungen, die oximverbindungen enthalten
TW197375B (enExample) 1990-11-19 1993-01-01 Hayashibara Biochem Lab
FR2680683B1 (fr) 1991-08-29 1993-11-12 Oreal Composition cosmetique filtrante contenant un polymere filtre a structure hydrocarbonee et une silicone filtre.
DE4308282C2 (de) 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
DE4434494A1 (de) 1994-09-27 1996-03-28 Henkel Kgaa 2-Hydroxy-1-ethanon-Derivate zum Färben keratinhaltiger Fasern
DE19704273A1 (de) 1996-03-08 1997-09-11 Basf Ag Verfahren zur katalytischen Herstellung von optisch aktiven Hydroxyketonen
DE10133202A1 (de) 2001-07-07 2003-01-16 Beiersdorf Ag Osmolyte enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
WO2004003198A1 (ja) * 2002-06-27 2004-01-08 Genox Research, Inc. アレルギー性疾患の検査方法、および治療のための薬剤
WO2004006878A1 (en) * 2002-07-10 2004-01-22 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
JP2004155681A (ja) * 2002-11-05 2004-06-03 Lion Corp 口腔バイオフィルム抑制剤および口腔用組成物
DE10337863A1 (de) 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
EP1871735B1 (de) 2005-04-19 2015-12-23 Merck Patent GmbH Antioxidantien
CN101809023A (zh) * 2007-09-28 2010-08-18 陶氏康宁公司 含有抗坏血酸的酯衍生物的有机基硅氧烷

Similar Documents

Publication Publication Date Title
JP2013537205A5 (enExample)
CN102227407B (zh) 丙型肝炎病毒抑制剂
EP4209494A1 (en) Ring-modified proline short peptide compound and use thereof
EP2452680B1 (en) Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
EP2787002B1 (en) Oleanolic acid amidate derivatives, preparation methods and uses thereof
WO2010097480A3 (en) Menthyl carbamate compounds as skin and/or hair lightening actives
EA201000552A1 (ru) Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в
UA80973C2 (uk) Інгібітори вірусу гепатиту с
MX2009008953A (es) Compuestos como inhibidores de angiogenesis.
JP2010070503A (ja) 抗真菌作用2−アミノトリアゾロピリジン誘導体
WO2016210289A1 (en) Chemical modulators of signaling pathways and therapeutic use
WO2016210247A1 (en) New methods of use for an anti-diarrhea agent
NZ596047A (en) Stabilized lipid formulation of apoptosis promoter
HRP20130959T1 (hr) Antikancerozni spojevi i farmaceutski pripravci koji ih sadrže
JP2015500885A5 (enExample)
JP2011516511A5 (enExample)
CN117956992A (zh) Menin-mll相互作用的抑制剂
DK2767538T3 (en) TETRANDRINDERIVATER with substituted 5-CARBON, PRODUCTION PROCESS AND USE THEREOF
WO2012026813A3 (en) Analogs of geranylgeranylacetone and uses thereof
SI3174881T1 (en) (1,2,4) triazolo (4,3-B) pyridazines for use in the treatment of proliferative diseases
WO2009134404A3 (en) Steroidal compounds as melanogenesis modifiers and uses thereof
EP2616040B1 (de) 2,2'-furoin-derivate und deren verwendung zur hautaufhellung
MY148903A (en) Di(hetero)arylclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
RU2016114904A (ru) Новая кристаллическая солевая форма 3-(1,2,4-триазоло[4,3-а]пиридин-3-илэтинил)-4-метил-n-(4-((4-метилпиперазин-1-ил)метил)-3-трифторметилфенил)бензамида для медицинского применения
NZ613333A (en) Derivatives of glyco-cf2-serine and glyco-cf2-threonine